Hosted on MSN13d
First patient dosed in Phase Ib Pompe disease trialThe Phase Ib trial is set to test a gene therapy designed to target a rare disorder that causes muscle and respiratory failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback